At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open Label Phase 1 Study to Compare the Safety and Tolerability of the AKST1210 Column at Different Blood-Flow Rates in Patients With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis (HD)
In Brief
A clinical study evaluating AKST1210 S-15 at 250 mL/min, AKST1210 S-15 at 450 mL/min, and 4 other interventions for End-Stage Renal Disease. Completed, enrolled 10 participants across 4 sites.
Detailed Summary
This study is to evaluate the safety and tolerability of the AKST1210 column at blood-flow rates greater than 250 mL/min in subjects with end-stage renal disease (ESRD) undergoing hemodialysis (HD). The study will assess the safety, tolerability, and impact on HD parameters when the AKST1210 column is used at a blood-flow of up to 450 mL/min.
Study Details
Timeline
Interventions
Procedure: Hemodialysis, AKST1210 column size 150mL and blood-flow rate at 250mL/min
Procedure: Hemodialysis, AKST1210 column size 150mL and blood-flow rate at 450mL/min
Procedure: Hemodialysis, AKST1210 column size 250mL and blood-flow rate at 250mL/min
Procedure: Hemodialysis, AKST1210 column size 250mL and blood-flow rate at 450mL/min
Procedure: Hemodialysis, AKST1210 column size 350mL and blood-flow rate at 250mL/min
Procedure: Hemodialysis, AKST1210 column size 350mL and blood-flow rate at 450mL/min